Literature DB >> 972697

Mechanisms of bone destruction in the development of skeletal metastases.

C S Galasko.   

Abstract

Entities:  

Mesh：

Year:  1976        PMID： 972697     DOI： 10.1038/263507a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  42 in total

1.  Parathyroid Hormone-related Protein in Breast Cancer Tissues: Relationship between Primary and Metastatic Sites.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.

Authors:  G van der Pluijm; H Vloedgraven; E van Beek; L van der Wee-Pals; C Löwik; S Papapoulos
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

4.  Neurophysiology of Cancer Pain: From the Laboratory to the Clinic.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 5.  The pathophysiology and management of spine metastasis from lung cancer.

Authors:  J S Greenberger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 6.  Targeted radionuclide therapy for bone metastases.

Authors:  V J Lewington
Journal:  Eur J Nucl Med       Date:  1993-01

Review 7.  The pathobiology of the osteoclast.

Authors:  T J Chambers
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

Review 8.  Molecular mechanisms of metastasis in prostate cancer.

Authors:  Noel W Clarke; Claire A Hart; Mick D Brown
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

Review 9.  Efficacy of oral etidronate for skeletal diseases in Japan.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

10.  Establishment of successively transplantable rabbit VX2 cancer cells that express enhanced green fluorescent protein.

Authors:  Hisashi Oshiro; Hidenobu Fukumura; Kiyotaka Nagahama; Itaru Sato; Kei Sugiura; Hiroaki Iobe; Emi Okiyama; Toshitaka Nagao; Yoji Nagashima; Ichiro Aoki; Shoji Yamanaka; Ayumi Murakami; Jiro Maegawa; Takashi Chishima; Yasushi Ichikawa; Yoshihiro Ishikawa; Takeshi Nagai; Masaharu Nomura; Kenichi Ohashi; Koji Okudela
Journal:  Med Mol Morphol       Date:  2014-02-27       Impact factor: 2.309
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.